Bank of New York Mellon
TBIO

Bank of New York Mellon’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bank of New York Mellon’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-222,270
Closed -$6.12M – 4584
2021
Q2 		$6.12M Sell
222,270
-21,444
-9% -$421K ﹤0.01% 2392
2021
Q1 		$4.02M Sell
243,714
-12,385
-5% -$282K ﹤0.01% 2544
2020
Q4 		$4.72M Buy
256,099
+18,660
+8% +$334K ﹤0.01% 2391
2020
Q3 		$3.23M Buy
237,439
+23,864
+11% +$368K ﹤0.01% 2430
2020
Q2 		$3.83M Buy
213,575
+71,467
+50% +$1.08M ﹤0.01% 2347
2020
Q1 		$1.42M Buy
142,108
+14,333
+11% +$117K ﹤0.01% 2736
2019
Q4 		$1.04M Buy
127,775
+25,211
+25% +$233K ﹤0.01% 3229
2019
Q3 		$1.02M Buy
102,564
+16,875
+20% +$159K ﹤0.01% 3173
2019
Q2 		$1.08M Buy
85,689
+5,544
+7% +$58.4K ﹤0.01% 3157
2019
Q1 		$816K Buy
80,145
+52,177
+187% +$400K ﹤0.01% 3305
2018
Q4 		$210K Buy
27,968
+14,081
+101% +$103K ﹤0.01% 3838
2018
Q3 		$139K Buy
+13,887
New +$162K ﹤0.01% 3991

Bank of New York Mellon's TBIO Position: Q3 2021 in Review

Bank of New York Mellon sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 222,270 shares — an estimated $6.12M sold.

Bank of New York Mellon first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $6.12M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Bank of New York Mellon reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 222,270 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $6.12M.
  • Bank of New York Mellon first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Bank of New York Mellon's Translate Bio, Inc. Common Stock position peaked at $6.12M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.